Benefit-Risk Considerations During Drug Product Development (8of14) REdI 2018

  Рет қаралды 5,051

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
FDA Regulatory Requirements for Clinical Investigators and Case Examples (9of14) REdI 2018
41:00
U.S. Food and Drug Administration
Рет қаралды 4,1 М.
Risk Evaluation and Mitigation Strategies (REMS) Compliance Program
57:37
U.S. Food and Drug Administration
Рет қаралды 13 М.
А что бы ты сделал? @LimbLossBoss
00:17
История одного вокалиста
Рет қаралды 10 МЛН
啊?就这么水灵灵的穿上了?
00:18
一航1
Рет қаралды 72 МЛН
Fake watermelon by Secret Vlog
00:16
Secret Vlog
Рет қаралды 25 МЛН
Advancing Transparency and Regulatory Science Activities on Risk Evaluation and Mitigation Strategy
48:50
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 1
1:33:53
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 2 - Part 2
1:39:03
ICH M12 Drug-Drug Interaction Studies Final Guidance
1:54:10
U.S. Food and Drug Administration
Рет қаралды 88
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 2
1:12:08
Global IDMP Implementation - Getting Closer to the Goal
1:25:26
U.S. Food and Drug Administration
Рет қаралды 48
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 3
1:17:23
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 4
1:01:38
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 2 - Part 1
1:31:22
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 2 - Part 3
1:52:53